Impact of type 2 diabetes on adenoma detection in screening colonoscopies performed in disparate populations. 2021

Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794-8173, United States.

BACKGROUND The Black/African Ancestry (AA) population has a higher prevalence of type 2 diabetes mellitus (T2DM) and a higher incidence and mortality rate for colorectal cancer (CRC) than all other races in the United States. T2DM has been shown to increase adenoma risk in predominantly white/European ancestry (EA) populations, but the effect of T2DM on adenoma risk in Black/AA individuals is less clear. We hypothesize that T2DM has a significant effect on adenoma risk in a predominantly Black/AA population. OBJECTIVE To investigate the effect of T2DM and race on the adenoma detection rate (ADR) in screening colonoscopies in two disparate populations. METHODS A retrospective cohort study was conducted on ADR during index screening colonoscopies (age 45-75) performed at an urban public hospital serving a predominantly Black/AA population (92%) (2017-2018, n = 1606). Clinical metadata collected included basic demographics, insurance, body mass index (BMI), family history of CRC, smoking, diabetes diagnosis, and aspirin use. This dataset was combined with a recently reported parallel retrospective cohort data set collected at a suburban university hospital serving a predominantly White/EA population (87%) (2012-2015, n = 2882). RESULTS The ADR was higher in T2DM patients than in patients without T2DM or prediabetes (35.2% vs 27.9%, P = 0.0166, n = 981) at the urban public hospital. Multivariable analysis of the combined datasets showed that T2DM [odds ratio (OR) = 1.29, 95% confidence interval (CI): 1.08-1.55, P = 0.0049], smoking (current vs never OR = 1.47, 95%CI: 1.18-1.82, current vs past OR = 1.32, 95%CI: 1.02-1.70, P = 0.0026), older age (OR = 1.05 per year, 95%CI: 1.04-1.06, P < 0.0001), higher BMI (OR = 1.02 per unit, 95%CI: 1.01-1.03, P = 0.0003), and male sex (OR = 1.87, 95%CI: 1.62-2.15, P < 0.0001) were associated with increased ADR in the combined datasets, but race, aspirin use and insurance were not. CONCLUSIONS T2DM, but not race, is significantly associated with increased ADR on index screening colonoscopy while controlling for other factors.

UI MeSH Term Description Entries

Related Publications

Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
January 2016, Annals of gastroenterology,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
May 2020, Scientific reports,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
September 2019, Gastrointestinal endoscopy,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
March 2019, Gastrointestinal endoscopy,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
July 2014, Journal of clinical gastroenterology,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
October 2021, Gastrointestinal endoscopy,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
January 2020, Frontline gastroenterology,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
January 2020, Gastrointestinal endoscopy,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
April 2020, JAAPA : official journal of the American Academy of Physician Assistants,
Dimitri F Joseph, and Ellen Li, and Samuel L Stanley Iii, and Yi-Cong Zhu, and Xiao-Ning Li, and Jie Yang, and Lorenzo F Ottaviano, and Juan Carlos Bucobo, and Jonathan M Buscaglia, and Joshua D Miller, and Rajesh Veluvolu, and Michele Follen, and Evan B Grossman
August 2006, The American journal of gastroenterology,
Copied contents to your clipboard!